相似文献
1
Genetic regulation of platelet receptor expression and function: application in clinical practice and drug development.
Arterioscler Thromb Vasc Biol. 2010 Dec;30(12):2372-84. doi: 10.1161/ATVBAHA.110.218131.
2
Pharmacogenetics of the antiplatelet effect of aspirin.
Curr Pharm Des. 2012;18(33):5294-308. doi: 10.2174/138161212803251907.
3
The contribution of platelet glycoproteins (GPIa C807T and GPIba C-5T) and cyclooxygenase 2 (COX-2G-765C) polymorphisms to platelet response in patients treated with aspirin.
Gene. 2013 Sep 10;526(2):118-21. doi: 10.1016/j.gene.2013.04.083. Epub 2013 May 18.
4
Platelet function and antiplatelet therapy in cardiovascular disease: implications of genetic polymorphisms.
Curr Vasc Pharmacol. 2011 Jul 1;9(4):479-89. doi: 10.2174/157016111796197224.
5
Common variations in platelet glycoproteins: pharmacogenomic implications.
Pharmacogenomics. 2001 Nov;2(4):341-52. doi: 10.1517/14622416.2.4.341.
6
Effect of glycoprotein IIb-IIIa receptor antagonism on platelet membrane glycoproteins after coronary stent placement.
Thromb Haemost. 1998 Dec;80(6):994-1001.
7
Association between insulin receptor substrate-1 polymorphisms and high platelet reactivity with clopidogrel therapy in coronary artery disease patients with type 2 diabetes mellitus.
Cardiovasc Diabetol. 2016 Mar 22;15:50. doi: 10.1186/s12933-016-0362-0.
8
Editorial: Paving the way for improved antiplatelet therapy.
Curr Pharm Des. 2012;18(33):5195-6. doi: 10.2174/138161212803251871.
9
Targeting glycoprotein VI and the immunoreceptor tyrosine-based activation motif signaling pathway.
Arterioscler Thromb Vasc Biol. 2014 Aug;34(8):1615-20. doi: 10.1161/ATVBAHA.114.303408. Epub 2014 Jun 12.
10
Receptor-mediated inhibitory mechanisms and the regulation of platelet function.
Sci China Life Sci. 2015 Dec;58(12):1299-301. doi: 10.1007/s11427-015-4966-5. Epub 2015 Nov 20.
引用本文的文献
1
The journal of thrombosis and thrombolysis: commemorating the written word in science and medicine: three decades and counting.
J Thromb Thrombolysis. 2024 Oct;57(7):1103-1108. doi: 10.1007/s11239-024-03012-y. Epub 2024 Jul 9.
2
Overview of platelet physiology: its hemostatic and nonhemostatic role in disease pathogenesis.
ScientificWorldJournal. 2014 Mar 3;2014:781857. doi: 10.1155/2014/781857. eCollection 2014.
3
Time-dependent changes in non-COX-1-dependent platelet function with daily aspirin therapy.
J Thromb Thrombolysis. 2012 Apr;33(3):246-57. doi: 10.1007/s11239-012-0683-0.
4
The pharmacogenetics of antiplatelet agents: towards personalized therapy?
Nat Rev Cardiol. 2011 Aug 9;8(10):560-71. doi: 10.1038/nrcardio.2011.111.
5
The genetics of common variation affecting platelet development, function and pharmaceutical targeting.
J Thromb Haemost. 2011 Jul;9 Suppl 1(Suppl 1):246-57. doi: 10.1111/j.1538-7836.2011.04359.x.
本文引用的文献
1
Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis.
JAMA. 2010 Oct 27;304(16):1821-30. doi: 10.1001/jama.2010.1543.
2
Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial.
Lancet. 2010 Oct 16;376(9749):1320-8. doi: 10.1016/S0140-6736(10)61274-3.
3
Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON-TIMI 38 trial: a pharmacogenetic analysis.
Lancet. 2010 Oct 16;376(9749):1312-9. doi: 10.1016/S0140-6736(10)61273-1.
4
The genetics of normal platelet reactivity.
Blood. 2010 Oct 14;116(15):2627-34. doi: 10.1182/blood-2010-04-262048. Epub 2010 Jul 7.
5
A combined genome-wide linkage and association approach to find susceptibility loci for platelet function phenotypes in European American and African American families with coronary artery disease.
BMC Med Genomics. 2010 Jun 7;3:22. doi: 10.1186/1755-8794-3-22.
6
Genome-wide meta-analyses identifies seven loci associated with platelet aggregation in response to agonists.
Nat Genet. 2010 Jul;42(7):608-13. doi: 10.1038/ng.604. Epub 2010 Jun 6.
7
Cytochrome 2C19*17 allelic variant, platelet aggregation, bleeding events, and stent thrombosis in clopidogrel-treated patients with coronary stent placement.
Circulation. 2010 Feb 2;121(4):512-8. doi: 10.1161/CIRCULATIONAHA.109.885194. Epub 2010 Jan 18.
8
Polymorphisms in platelet glycoproteins Ia and IIIa are associated with arterial thrombosis and carotid atherosclerosis in type 2 diabetes.
Thromb Haemost. 2010 Mar;103(3):630-7. doi: 10.1160/TH09-07-0453. Epub 2010 Jan 13.
9
Novel loci, including those related to Crohn disease, psoriasis, and inflammation, identified in a genome-wide association study of fibrinogen in 17 686 women: the Women's Genome Health Study.
Circ Cardiovasc Genet. 2009 Apr;2(2):134-41. doi: 10.1161/CIRCGENETICS.108.825273. Epub 2009 Feb 12.
10
VAMP8/endobrevin is overexpressed in hyperreactive human platelets: suggested role for platelet microRNA.
J Thromb Haemost. 2010 Feb;8(2):369-78. doi: 10.1111/j.1538-7836.2009.03700.x. Epub 2009 Nov 23.
Zotero 插件